STAT

Plastic tubes can’t save the lives of liver failure patients, and a biotech’s stock price plummets

Another effort by Vital Therapies to transform plastic tubes into a lifesaving artificial liver ended in disappointment.

Another effort by Vital Therapies () to transform into a lifesaving artificial liver ended in disappointment Wednesday. And after this latest setback, the

You're reading a preview, sign up to read more.

More from STAT

STAT9 min readScience
The ‘Unbelievable Journey’ Of CRISPR, Now On Netflix
"Unnatural Selection," a four-part docuseries debuting today, dissects the stories, science, and ethics behind genome editing.
STAT5 min read
Competitor Accuses 23andMe Of ‘False Negatives’ In Cancer-gene Testing
23andMe is pushing back hard on a new study from a competitor that accuses the company of 'false negatives' in its cancer-gene testing.
STAT4 min read
Opinion: As The Need For Organ Transplants Grows, The Number Of Transplant Physicians Dwindles
Medical training has been long been characterized as a "grand bargain" in which trainees make personal sacrifices with the expectation of a better life later. But that's a deal many…